Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study

Giannini, 2006, Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma, Clin Gastroenterol Hepatol, 4, 1378, 10.1016/j.cgh.2006.08.011 Lang, 2004, Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding, Am J Gastroenterol, 99, 2158, 10.1111/j.1572-0241.2004.40336.x Ripoll, 2013, Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicentre case–control study, Hepatology, 58, 2079, 10.1002/hep.26629 de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Amitrano, 2005, MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices, J Hepatol, 42, 820, 10.1016/j.jhep.2005.01.021 del Olmo, 2000, Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis, J Hepatol, 32, 19, 10.1016/S0168-8278(01)68827-5 Boyer, 2005, The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension, Hepatology, 41, 386, 10.1002/hep.20559 Kobayakawa, 2017, Short-term safety and efficacy of balloon-occluded retrograde transvenous obliteration using ethanolamine oleate: results of a prospective, multicentre, single-arm trial, J Vasc Interv Radiol, 28, 1108, 10.1016/j.jvir.2017.03.041 Gwon, 2015, Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicentre study, J Vasc Interv Radiol, 26, 1589, 10.1016/j.jvir.2015.07.011 Sarin, 1992, Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients, Hepatology, 16, 1343, 10.1002/hep.1840160607 Kobayakawa, 2019, Recent development of balloon-occluded retrograde transvenous obliteration, J Gastroenterol Hepatol, 34, 495, 10.1111/jgh.14463 Hong, 2009, Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration, J Gastroenterol Hepatol, 24, 372, 10.1111/j.1440-1746.2008.05651.x Sabri, 2011, Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam, J Vasc Interv Radiol, 22, 309, 10.1016/j.jvir.2010.11.022 Stein, 2019, Balloon retrograde transvenous obliteration versus endoscopic cyanoacrylate in bleeding gastric varices: comparison of rebleeding and mortality with extended follow-up, J Vasc Interv Radiol, 30, 187, 10.1016/j.jvir.2018.12.008 Akahane, 1997, Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration, Am J Gastroenterol, 92, 1026 Matsuoka, 2014, Usefulness of balloon-occluded retrograde transvenous obliteration for gastric varices concurrent with hepatocellular carcinoma, Hepatogastroenterology, 61, 2301 Heimbach, 2018, AASLD guidelines for the treatment of hepatocellular carcinoma, Hepatology, 67, 358, 10.1002/hep.29086 Sarin, 1989, Gastric varices: profile, classification, and management, Am J Gastroenterol, 84, 1244 de Franchis, 2010, Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 53, 762, 10.1016/j.jhep.2010.06.004 2010, EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, J Hepatol, 53, 397, 10.1016/j.jhep.2010.05.004 Vilstrup, 2014, Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver, Hepatology, 60, 715, 10.1002/hep.27210 Lencioni, 2010, Modified RECIST (mRECIST) assessment for hepatocellular carcinoma, Semin Liver Dis, 30, 52, 10.1055/s-0030-1247132 Sacks, 2003, Society of Interventional Radiology clinical practice guidelines, J Vasc Interv Radiol, 14, S199, 10.1097/01.RVI.0000094584.83406.3e Liu, 2014, Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis, Hepatol Res, 44, 621, 10.1111/hepr.12162 Bettinger, 2015, Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma, Aliment Pharmacol Ther, 41, 126, 10.1111/apt.12994 Qiu, 2015, Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension, World J Gastroenterol, 21, 12439, 10.3748/wjg.v21.i43.12439 Lee, 2014, Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results, Clin Transl Gastroenterol, 5, e61, 10.1038/ctg.2014.12 Takuma, 2005, Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis, Clin Gastroenterol Hepatol, 3, 1245, 10.1016/S1542-3565(05)00744-5 Cho, 2007, Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients, AJR Am J Roentgenol, 189, W365, 10.2214/AJR.07.2266 Chang, 2016, Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage, Korean J Radiol, 17, 230, 10.3348/kjr.2016.17.2.230 Ninoi, 2005, Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients, AJR Am J Roentgenol, 184, 1340, 10.2214/ajr.184.4.01841340 Hiraga, 2007, The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration, J Gastroenterol, 42, 663, 10.1007/s00535-007-2077-1 Chang, 2016, Efficacy and safety of balloon-occluded retrograde transvenous obliteration with sodium tetradecyl sulfate liquid sclerotherapy, Korean J Radiol, 17, 224, 10.3348/kjr.2016.17.2.224